Cryo Cell International CCEL
NYSE CCEL
$4.04 -0.06 (-1.45%)
As of: Sep 3, 2026 · 10:56 AM EDT

Cryo Cell International (CCEL) EBITDA Margin Growth (1y) (2011 - 2026)

Analysis

Cryo Cell International (CCEL) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 HCA Healthcare 90.36 Bn 89.35 Bn 15.19 Bn -519.00
2 Tenet Healthcare 22.02 Bn 19.85 Bn 4.45 Bn 1,106.00
3 Encompass Health 12.13 Bn 11.99 Bn 1.34 Bn -101.00
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn 38.00
5 Universal Health Services 10.09 Bn 9.95 Bn 3.29 Bn -54.00
6 Ensign 9.97 Bn 9.65 Bn 306.24 Mn 4.00
7 Chemed 6.93 Bn 6.89 Bn 221.47 Mn 215.00
8 Pacs 6.81 Bn 6.64 Bn 338.46 Mn 151.00
9 Concentra Group Holdings Parent 4.32 Bn 4.16 Bn 192.10 Mn 273.00
10 Cryo Cell International 32.55 Mn 29.39 Mn 6.10 Mn -343.00
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 -343.00
Feb 28, 2026 -329.00
Nov 30, 2025 -4,905.00
Aug 31, 2025 706.00
May 31, 2025 152.00
Feb 28, 2025 279.00
Nov 30, 2024 20,384.00
Aug 31, 2024 248.00
May 31, 2024 408.00
Feb 29, 2024 -1,105.00
Nov 30, 2023 -21,059.00
Aug 31, 2023 233.00
May 31, 2023 -242.00
Feb 28, 2023 125.00
Nov 30, 2022 1,627.00
Aug 31, 2022 -885.00
May 31, 2022 -1,204.00
Feb 28, 2022 225.00
Nov 30, 2021 -3,996.00
Aug 31, 2021 -929.00